Palbociclib Sandoz Capsule 75mg

Manufacturer
Aizant Drug Research Solutions Pvt. Ltd.(INDIA)

Registraction Number
MAL24106017AZ

Content:

• Active Ingredient: Palbociclib 75mg
• Excipients: Various inactive ingredients to stabilize the capsule

• Hormone Receptor-Positive (HR-positive), HER2-negative Advanced Breast Cancer: Used in combination with an aromatase inhibitor as the first-line treatment in postmenopausal women.
• Hormone Receptor-Positive (HR-positive), HER2-negative Advanced Breast Cancer: Used in combination with fulvestrant in women who have received prior endocrine therapy.

1. Dosage and Administration: The typical dose is 125mg (one capsule) taken orally once daily for 21 consecutive days, followed by 7 days off treatment (28-day cycle). Always follow the dosage instructions provided by your healthcare provider.
2. Storage: Store at room temperature, away from moisture and heat.
3. Handling: Take the capsule with a full glass of water. Do not crush or chew the capsule.
4. Monitoring: Regular monitoring of blood counts and other relevant parameters as advised by the healthcare provider.